Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PRR15 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of PRR15 mRNA | CTD | PMID:30165855 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PRR15 mRNA | CTD | PMID:31614463 | 17beta-estradiol | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of PRR15 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRR15 mRNA | CTD | PMID:19933214 and PMID:32553695 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRR15 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRR15 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Prr15 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRR15 mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRR15 mRNA | CTD | PMID:19770486 and PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRR15 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 6-propyl-2-thiouracil | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PRR15 mRNA | CTD | PMID:24780913 | 7,12-dimethyltetraphene | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | acetamide | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of PRR15 mRNA | CTD | PMID:31881176 | amphetamine | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of PRR15 mRNA | CTD | PMID:30779732 | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PRR15 mRNA | CTD | PMID:19770486 and PMID:21715664 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PRR15 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in decreased expression of PRR15 mRNA | CTD | PMID:32553695 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PRR15 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bexarotene | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of PRR15 mRNA | CTD | PMID:17630414 | bisphenol A | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of PRR15 mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PRR15 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | ISO | Prr15 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PRR15 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PRR15 mRNA | CTD | PMID:27685785 | bisphenol A | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PRR15 mRNA | CTD | PMID:25181051 more ... | carbon nanotube | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of PRR15 mRNA | CTD | PMID:25554681 | chloroprene | decreases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Chloroprene results in decreased expression of PRR15 mRNA | CTD | PMID:23125180 | choline | multiple interactions | ISO | Prr15 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | Prr15 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PRR15 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PRR15 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in decreased expression of PRR15 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in decreased expression of PRR15 mRNA | CTD | PMID:26033743 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of PRR15 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of PRR15 protein | CTD | PMID:25047351 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of PRR15 mRNA | CTD | PMID:25562108 | cyclosporin A | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of PRR15 mRNA | CTD | PMID:19770486 | dichloroacetic acid | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of PRR15 mRNA | CTD | PMID:28962523 | dioxygen | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of PRR15 mRNA | CTD | PMID:20880076 | diquat | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Diquat results in increased expression of PRR15 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of PRR15 mRNA | CTD | PMID:29391264 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of PRR15 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | ISO | Prr15 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene | CTD | PMID:20938992 | genistein | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Genistein results in increased expression of PRR15 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PRR15 mRNA | CTD | PMID:33387578 | glycidol | increases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | glycidol results in increased expression of PRR15 mRNA | CTD | PMID:24915197 | GW 4064 | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of PRR15 mRNA | CTD | PMID:26655953 | irinotecan | multiple interactions | ISO | Prr15 (Mus musculus) | 6480464 | [PHY 906 co-treated with Irinotecan] affects the expression of PRR15 mRNA | CTD | PMID:32812032 | L-methionine | multiple interactions | ISO | Prr15 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene | CTD | PMID:20938992 | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of PRR15 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PRR15 mRNA | CTD | PMID:33387578 | paraquat | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | Paraquat results in increased expression of PRR15 mRNA | CTD | PMID:21463325 | pirinixic acid | multiple interactions | ISO | Prr15 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PRR15 mRNA | CTD | PMID:19710929 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of PRR15 mRNA | CTD | PMID:20864642 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of PRR15 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of PRR15 mRNA | CTD | PMID:23806026 and PMID:25895662 | sodium arsenate | decreases expression | ISO | Prr15 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of PRR15 mRNA | CTD | PMID:21795629 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of PRR15 mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium dodecyl sulfate | increases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased expression of PRR15 mRNA | CTD | PMID:31734321 | tamoxifen | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of PRR15 mRNA | CTD | PMID:17630414 | testosterone | multiple interactions | ISO | Prr15 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of PRR15 mRNA | CTD | PMID:26496021 | titanium dioxide | increases expression | ISO | Prr15 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of PRR15 mRNA | CTD | PMID:23557971 | trichloroethene | decreases expression | ISO | Prr15 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of PRR15 mRNA | CTD | PMID:33387578 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of PRR15 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PRR15 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA | CTD | PMID:27188386 | |